| Tag | Content |
|---|
EnhancerAtlas ID | HS045-03195 |
Organism | Homo sapiens |
Tissue/cell | Fetal_lung |
Coordinate | chr1:101108350-101109970 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ALX3 | MA0634.1 | chr1:101109896-101109906 | TCTAATTAAA | + | 6.02 | | HNF1A | MA0046.2 | chr1:101109584-101109599 | ATTTAATTATTAACT | + | 6.31 | | HNF1A | MA0046.2 | chr1:101109584-101109599 | ATTTAATTATTAACT | - | 6.61 | | HNF1B | MA0153.2 | chr1:101109585-101109598 | TTTAATTATTAAC | - | 6.24 | | mix-a | MA0621.1 | chr1:101108808-101108819 | ACTAATTAATT | - | 6.62 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_45780 | chr1:101108279-101110109 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 101108952 | 101109002 | | chr1 | 101109048 | 101109662 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I100643 | chr1 | 101109441 | 101109589 |
|
Enhancer Sequence | GCCAGAGCTA TGCAAGGCCA AAGTGTGCAG AAAGTAACAA TTGAGAAAAT ACATTAATGA 60
GATGAGCCAA TAATTATTCA AGACAGGAAA GTCTTTAAAC TTAACTGCTC AGCTCCTTCT 120
AGTCATCCCT AAAGAAAGCT CCAGCTTGGA CAAGGATCTG TCAAATTCAT AACACCCATG 180
GGTTAAGGAA TTCCCCATTC TTGGTAGGAA AAGTTATATC ACTACTCTCC TGTGGTCATA 240
AATATTCAGT TAACCCATGT AATGTGCCTG CAGAGTGTTT GGCATGTGGC ATTCTCAGTG 300
AACATTAGTT CCTTCCTTTC TAGTTTCAAG GTATGCAAAA GGCCATTTAG CAAGAAGCGA 360
CTCCTGACCC CATCTCGTGA AGGTGGAGCT GACCTGGCTT TGTCATCAAC ATGTTGATGA 420
CTCTCTACTC ATTTGGGTCC CTCGTGTAGC CACATGCTAC TAATTAATTT GAAGAAAATT 480
AATAGTCATC ACTGTTTTCT AAAGTGTGTA TGTAAATTCC AACTTAGGAA CAAAGTTGAT 540
AGTCACTGAA GAGTAGTTGC CTACATAGTG TATAAAATAG TCTGCTCTGA TCCAAGTTCC 600
TTTGAAACAA AGTTAAATTG GTGCAACAGA AGTTAAGTTC ATCAGAAAGG AAAAGATTAG 660
AGGGCTACAC TAGTCACTAT GATAAGGACT TGATAGAGTT TTGCAGAAAA AGTTTGATTG 720
ACTCATTTGT AAGAATTCTA AATAAAGATA TATAAATGAA GGTAAAATGA CCTCAGAATG 780
AACAATGTCA TGAGAATCCA AGCTGTTACA TCCGGTATTA GCAGAAACTT TCAGCAGCAC 840
ACCCTAGTAT GAAGGGCCGA TAACAAATAC TGTAATTCAA GTGAGGAACA GCCTTACTTT 900
CCAGAACTGC CCAGTTAATC AAAAAGTCTG GAACTATTCC CGGGATTTTT TTTTTAAATC 960
TAGAAAAAAA ACCTCAAGAT AACCCTTGTA AAATTGATCT AACATCAATG GGATGTGAGA 1020
AGGTAGTTAT AGGTTTGCAT TATCAAAGGG GTTTTACAAA AAATAAAGTG ATTTGCAAAA 1080
CGAGACTAAG GTAGAAAAGG TAAACACATA TCATTTGTGT GTGGTGATTG GAGGAGAGTT 1140
GGGGAGGGCA GGGGAGCATT CAAGGGAATG AAGAAACAGT TTTACAATGT GGAGGAAGTT 1200
GGTCAGACTT CAGCTTCCCC AGAGGATAAG CAAAATTTAA TTATTAACTT GTTCTTGGCA 1260
CCAGATTTAT TCCCCACAGA AAAACTTTAA ATCAAACCTA GAAATAACTC TAAGAGAGAA 1320
GAGGAGACAT TTTATTTGAA CATGTGTGCT GTAGATGAAA TGGTAAGTGG AAATCTGTTT 1380
ATTCTCACTG ATTATTTCCA TGTGGAAGTT GCAAATCCTA CAGTGGCCAA TGGAAAAGGT 1440
AAAGTTAGAT GAGAGCATCA TTTATTCCTT GGTGAAAAAG TATCCCTCAG TAATTACAAG 1500
GGATCCATAG GCAGCTTTGT GTTGTAGCAC GAGTCTTGAA GTTGACTCTA ATTAAAGCCC 1560
TCTCATCTTT CCAAGAATTC TTAATGACCA TAATCTTTGG TACTTTAGCA TTGATGTAGT 1620
|
